# Novartis’ TREM2 drug fails Phase 2 ALS trial

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-16 18:29 UTC · Category: Business · Sources: 6 · Current Velocity: 3.67

## Key People, Organizations & Locations
ALS, Phase, Novartis, TREM2

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| BioSpace | Novartis halts TREM2 targeting ALS program in 4th trial stumble in a month | 2026-09-16 11:24 | [Source Link](https://news.google.com/rss/articles/CBMitwFBVV95cUxOTjdHUGxsSFhMdXlIVkhvdEJKbHFXLXFBdF9Zb2lEdXllVXQzWmZ2ajRWVGlQUXBqOGtQWDBzRXZFUEt3ekxPMWtzUjBCcnROZUs4enNSS2s4QlVBbG50c1BSRGd1Sk1ZNHRLWXhhczNnVWhXUEtrOHNKM0x3WUxVbWFDMkE1SjJRQ04yLURiSk82TzJqUEZDRnREcURnT00zLXRNczR3X2JRazh1VkJrTlZnTnpmTzA?oc=5) |
| Reuters | Novartis halts ALS drug development after mid-stage trial failure | 2026-09-16 11:24 | [Source Link](https://news.google.com/rss/articles/CBMi0wFBVV95cUxOXzQ0aGlxRTVDWHZadUloUUk2bGhfMDAxdEkybkI3VnhQeVpjeUREX2dNSU9hOGZRb0M2TWhDV1lLSXhDem9KRnQwQ0dtYkgwTEJtSmRfNlA1WUhkZ3VOcFgzbXRXWmNBWHA2RU1NdXI1el9LV05vVUNIeXJvYV9URUpzUmQ2ZzZiUnlUbzZ6cGhIcklldC0xeHVNa3c2eThjLUJYaVZ0X2NMV3JBTmFXSmFLemY1Qng3aHlnUVhqX3VlNUY0bGhKQlAtR0dYODE5bUJB?oc=5) |
| Fierce Biotech | Novartis ends ALS program after phase 2 flop, adding to R&D woes | 2026-09-16 11:24 | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxQa3VXcGFxbEhpd1lDQ0hteXVzVTFjbzVGSnBCSG13akc3T0E3enRjams5RERTMVN1MkktX25hNGJKWnozRV9xUWxHRV9Na1IxRTk2TjJaMDktRDQ4c1pxVE1NN1N6Q1A2ZWZseWk5MHFoTmZXVl8zcXBuZnZkMGVuNVVhNzVmQWNuMWVKMkFGc0d3aGJweDZyTGtkb05SUQ?oc=5) |
| Investor's Business Daily | Novartis Suffers Another Setback After Stock-Rocking Failures | 2026-09-16 11:24 | [Source Link](https://news.google.com/rss/articles/CBMie0FVX3lxTE5WVTQyeWdsYkF1TDFHaFQ2bE5jNktkR0l2aGVubjhKd0hCZHBkdW9uUHJPYmgxd3dPaGthOFJmX0NMNUZTMjV1cm9BZUFmSTNhUjlwdHVVS012aG9tdVpVWGNySlJMMVFuTE9rYlo3TE5fN2ZvX1RyQTNCMA?oc=5) |
| Bloomberg.com | Novartis Experimental Drug for ALS Fails in Another Pipeline Hit | 2026-09-16 11:24 | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxPVFRWM05TQlNEYTZXQTZnYmxnbmhuaTRadmt2NXNXOVBmSXFJcXVlNmlmU3QteUhsalZFREFTWlJmWW5MOFJVT3huUm85bEdaOXVFbE85d0NLS3N4dFRsRUUzVl9qMk80cmV5LWpDT0c1ZDRydjdxQmVOYlZ6dE9lbmZ0NHJMUkNhdFdOOGI4UnY1S2dZNjhsUGE3Y1JTYlRlanVoem9xb0tUbVpWeHBDRGVwUU12QQ?oc=5) |
| Endpoints News | Novartis’ TREM2 drug fails Phase 2 ALS trial | 2026-09-16 11:24 | [Source Link](https://news.google.com/rss/articles/CBMidkFVX3lxTFBNMWxIYVBLaEtqSGVnaHZKSWw4M25Da1VWOGFIcU5wUUdVNng4OUxadFVXOS1veEExUldnX1VidWZEd2R0amZQUDdZdGRJbWdlajAxTWdfMlNUMFc1TXZwOGpSOXlWckZPanhSdHZ6cWZ0dExmNVE?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-16/novartis-trem2-drug-fails-phase-2-als-trial*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*